Coal dust-mimetic carbon nanoparticles (CNPs) delivered intranasally to rats over 4–12 weeks produced significant colonic damage: reduced daily weight gain, elevated spleen index, intestinal barrier dysfunction, gut microbiota dysbiosis, and robust inflammatory responses. Transcriptomic sequencing combined with in vivo and in vitro experiments revealed that CNP exposure drives mitochondrial deterioration — altered morphology, elevated reactive oxygen species, and collapsed membrane potential — simultaneously activating p16 and p21 cell-cycle arrest pathways, effectively locking colonic epithelial cells in a senescent state. The authors identify this p16/p21 dual axis as the molecular switch governing CNP-induced colitis.
The occupational angle here is underexplored yet clinically consequential: coal miners globally carry disproportionately high inflammatory bowel disease burdens, and mechanistic explanations have been scarce. Connecting inhaled particulate matter to gut pathology via a gut–lung axis and mitochondria-driven senescence is conceptually important, extending the cellular senescence hypothesis of IBD into an environmental toxicology context. The p16/p21 senescence pathway has attracted significant pharmaceutical attention — senolytics and senomorphics are active drug development targets — making this a potentially actionable finding. Key limitations: the model relies on intranasal CNP instillation in rats, not true inhalation or human occupational exposure; causality in humans remains unestablished; and CNPs, while compositionally mimetic, may not fully replicate complex coal dust chemistry. Still, for a field lacking mechanistic clarity, this is a meaningful and directionally important step — confirmatory work in human colon organoids or epidemiological validation would substantially elevate its impact.